In this issue:
Quality performance indicators for surgical management
The efficacy of ICIs
Additional trastuzumab as preoperative treatment
2-year follow-up of phase II WuhanUHGI001 trial
Additional D2 dissection
Nivolumab plus chemotherapy
Bemarituzumab in addition to mFOLFOX6
RTG versus LTG
Feasibility and efficacy of digital therapeutics
Effects of discontinued neoadjuvant therapy
Please login below to download this issue (PDF)